Blood-Brain Barrier in Cerebral Malaria: Pathogenesis and Therapeutic Intervention.

Blood-Brain Barrier in Cerebral Malaria: Pathogenesis and Therapeutic Intervention.
Trends Parasitol. 2019 May 27;:
Authors: Nishanth G, Schlüter D
Abstract
Cerebral malaria is a life-threatening complication of malaria caused by the parasite Plasmodium falciparum. The growing problem of drug resistance and the dearth of new antiparasitic drugs are a serious threat to the antimalaria treatment regimes. Studies on humans and the murine model have implicated the disruption of the blood-brain barrier (BBB) in the lethal course of the disease. Therefore, efforts to alleviate the BBB dysfunction could serve as an adjunct therapy. Here, we review the mechanisms associated with the disruption of the BBB. In addition, we discuss the current, still limited, knowledge on the contribution of different cell types, microparticles, and the kynurenine pathway in the regulation of BBB dysfunction, and how these molecules could be used as potential new therapeutic targets.
PMID: 31147271 [PubMed - as supplied by publisher]

Source: Trends in Parasitology - May 26, 2019 Category: Parasitology Authors: Nishanth G, Schlüter D Tags: Trends Parasitol Source Type: research